What is Cognitive Behavioral Therapy for Chronic Pain?
Did you know that pain is the number one reason Americans access the health care system? Chronic pain, which is pain that persists on most days for at least three months, is the leading cause of long-term disability in the United States, affecting 50 million adults. Twenty million adults experience high-impact chronic pain, limiting their […]
Let’s Talk About Mental Health Among Professional Athletes
Mental health has been a topic of interest in the sports world for a while, as an increasing number of athletes are stepping forward to talk about their personal struggles with mental illness. According to the National Institute of Mental Health, approximately one in five adults in the U.S are affected by mental illness each year, and […]
Prescription Medication Abuse: What You Should Know
When people think about drug abuse, they often think about illicit drugs like heroin or cocaine. While these drugs are widely abused, many people also abuse prescription medications. Prescription drug abuse is the use of prescription medication in any way other than how the physician prescribed it. For example, a person may take a higher […]
5 Myths About Mental Illness
According to the Centers for Disease Control and Prevention (CDC), one in five U.S. adults experiences mental illness every year, meaning there’s a good chance you or someone you know is affected by mental health problems at any given time. Mental illness can affect anyone, regardless of a person’s age, gender, geography, income, social status, race […]
Q3 2021 Newsletter
Table of Contents Add a header to begin generating the table of contents ZICOH Last quarter, Vivera realized breakthroughs in ZICOH® technology for both intellectual property and research and development (R&D) viewpoints. Most notably, ZICOH® technology was awarded two patents from the United States Patent and Trademark Office (USPTO). On August 10, ZICOH® received its first patent, […]
What Happens During Opioid Withdrawal?
When a person takes opioids for a prolonged period of time, they often develop a tolerance to the drug, meaning they need a larger dose to obtain the same effect. Over time, a person may become dependent on opioids, during which they begin to need them just to feel “normal,” otherwise they experience withdrawal symptoms. […]
Why Are Physician Suicide Rates So High?
Did you know, physicians have higher rates of depression than the general population? Physicians die by suicide at a rate that is near double that of the general population, with an estimated 300 to 400 U.S. physicians taking their own lives every year. According to Medscape’s National Physician Burnout & Suicide Report 2021, thirteen percent […]
Vivera Pharmaceuticals Joins Forces with DoctorsOne Healthcare Systems and Manny Pacquiao Foundation for Vaccine Campaign in Underserved SoCal Communities
NEWPORT BEACH, Calif. – Vivera Pharmaceuticals, Inc., in partnership with DoctorsOne Healthcare Systems (Doc1 Health) and the Manny Pacquiao Foundation, announced the launch of a joint vaccination initiative in Southern California. By bringing together each teams’ respective expertise, the initiative strives to increase awareness for the low vaccination rates among underserved communities of Los Angeles County. […]
Why Are So Many Seniors in Chronic Pain?
Chronic pain affects about 20 percent of adults in the United States, with a large portion being over 65 years old. Unfortunately, pain is often undertreated and possibly even underreported among older adults. Instead, it is commonly written off as a normal part of aging. But pain should not be accepted when it affects a person’s […]
$500 Million Defamation Lawsuit Against USA Today and Its Executives Continues as Vivera Receives More Favorable Decisions
NEWPORT BEACH, Calif. – Vivera Pharmaceuticals, Inc. continues to move forward in its defamation lawsuit filed in Virginia state court against USA Today and its parent companies, Gannett Co., Inc. and Gannett Satellite Information Network, LLC (“Gannett”). “USA Today published an article that was nothing more than a hit-piece on my professional reputation and over […]
